Phytochemical Investigation and In-vitro Antiulcer Activity Evaluation of Flavonoids Rich Fraction of Alternanthera sessilis Leaf Ethanolic Extract
International Journal of Drug Delivery Technology · 25.12.2025 · 15 (04)
DOI: 10.25258/ijddt.15.4.31 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 25.12.2025. Verfasst von Arshu Patel und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Objectives
Examining the acid-neutralizing ability, H⁺/K⁺ ATPase and Na⁺/K⁺ ATPase modulation of the flavonoid-rich fraction of Alternanthera sessilis leaf ethanolic extract, as well as its phytochemical profile and in-vitro antiulcer efficacy, were the primary goals of the research.
Methods
Leaves of A. sessilis were collected, shade-dried, and extracted using Soxhlet extraction with ethanol. Preliminary phytochemical screening and TLC profiling were performed, followed by column chromatography to obtain two major fractions. GC-MS analysis identified key bioactive compounds in both fractions. Among them, Fraction 2, enriched in flavonoids, was selected for In-vitro evaluation. Antiulcer assays included Acid Neutralizing Capacity (ANC), H⁺/K⁺ ATPase and Na⁺/K⁺ ATPase inhibition models using standard protocols with omeprazole and ouabain as reference drugs.
Results
Fraction 2 demonstrated the highest ANC of 120 mEq/g at 100 mg concentration compared to calcium carbonate (37.8 mEq/g). In H⁺/K⁺ ATPase inhibition assay, Fraction 2 showed 58.90% inhibition at 100 µg/mL with an IC₅₀ of 91.1 µg/mL, whereas omeprazole had an IC₅₀ of 55.9 µg/mL. Similarly, in the Na⁺/K⁺ ATPase assay, Fraction 2 exhibited 43.50% inhibition at 100 µg/mL (IC₅₀: 91.1 µg/mL), compared to 80.51% inhibition by ouabain (IC₅₀: 55.9 µg/mL). The optimized fraction was selected based on GC-MS profiling and comparative bioactivity across all In-vitro assays.
Conclusion
The optimized flavonoid-rich fraction of A. sessilisshows significant antiulcer potential via multi-targeted mechanisms and offers a promising, natural alternative for acid-related disorders. These findings support further in-vivo validation and highlight the potential for future clinical translation as a standardized phytopharmaceutical.
Zitieren
APA
Patel, A., Jadhav, P., Deshpande, A., Kothawade, K., Shaikh, W., & Daphal, G. (2025). Phytochemical Investigation and In-vitro Antiulcer Activity Evaluation of Flavonoids Rich Fraction of Alternanthera sessilis Leaf Ethanolic Extract. International Journal of Drug Delivery Technology, 15(04). https://doi.org/10.25258/ijddt.15.4.31
Vancouver
Patel A, Jadhav P, Deshpande A, Kothawade K, Shaikh W, Daphal G. Phytochemical Investigation and In-vitro Antiulcer Activity Evaluation of Flavonoids Rich Fraction of Alternanthera sessilis Leaf Ethanolic Extract. International Journal of Drug Delivery Technology. 2025;15(04). doi:10.25258/ijddt.15.4.31
BibTeX
@article{Patel2025,
author = {Patel, Arshu and Jadhav, Punam and Deshpande, Ajay and Kothawade, Kishor and Shaikh, Wasim and Daphal, Gajanan},
title = {Phytochemical Investigation and In-vitro Antiulcer Activity Evaluation of Flavonoids Rich Fraction of Alternanthera sessilis Leaf Ethanolic Extract},
journal = {International Journal of Drug Delivery Technology},
year = {2025},
volume = {15},
number = {04},
doi = {10.25258/ijddt.15.4.31}
}
EUVIMED